跳至主要内容
临床试验/NCT00574119
NCT00574119已完成4 期

Effect of Aldosterone on Energy Starvation in Heart Failure

Vanderbilt University1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2007年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
16
试验地点
1
主要终点
Myocardial Perfusion Index Reserve (MPRI) by Magnetic Resonance Imaging at 6 Months

研究概览

简要总结

We plan to study the concept of "energy starvation" in heart failure by evaluation of patients with nonischemic dilated cardiomyopathy (NIDCM) (heart failure with reduced heart pump function due to causes other than heart attack). We will use a combination of positron emission tomography and magnetic resonance imaging to study metabolism, anatomy, function, blood flow and efficiency, before and after 6 months' treatment with the drug spironolactone which blocks the deleterious effects of the hormone aldosterone on the myocardium (heart muscle).

详细描述

Preliminary results showed reduced subendocardial myocardial perfusion reserve in NIDCM compared to normal subjects, and that the degree of impaired perfusion reserve was related to the oxidative metabolic rate as measured by positron emission tomography.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older
  • Nonischemic dilated cardiomyopathy
  • Left ventricular ejection fraction 35% or less
  • Stable heart failure symptoms
  • Able to undergo both positron emission tomography and magnetic resonance imaging with gadolinium
  • Able to tolerate treatment with spironolactone

排除标准

  • Serum potassium >5.0
  • Serum creatinine >2.5
  • Contraindications to magnetic resonance imaging such as internal cardioverter-defibrillator.

研究组 & 干预措施

Results with spironolactone

Experimental

patients with heart failure due to nonischemic dilated cardiomyopathy will be studied by 11C acetate positron emission tomography and magnetic resonance imaging using vasodilator and gadolinium to judge myocardial blood flow, before and after 6 months' treatment with spironolactone.

干预措施: spironolactone (Drug)

结局指标

主要结局

Myocardial Perfusion Index Reserve (MPRI) by Magnetic Resonance Imaging at 6 Months

时间窗: 6 months

MPRI =calculated myocardial perfusion reserve index based on Gadolinium accretion into myocardium. MPRI was calculated as the ratio of stress/rest relative perfusion upslope, corrected for LV cavity upslope.

Change in Myocardial Fibrosis (T1 Time) by Magnetic Resonance Imaging

时间窗: baseline and 6 months

T1=left ventricular relaxation rate on magnetic resonance imaging, which is correlated with interstitial fibrosis.

Left Ventricular Work-metabolic Index (WMI) at Baseline

时间窗: baseline

WMI=\[left ventricular stroke work/decay rate of 11C-acetate\]

Myocardial Perfusion Reserve Index (MPRI) by Magnetic Resonance Imaging at Baseline

时间窗: baseline

MPRI =calculated myocardial perfusion reserve index based on Gadolinium accretion into myocardium. MPRI was calculated as the ratio of stress/rest relative perfusion upslope, corrected for LV cavity upslope.

Left Ventricular Work-metabolic Index (WMI) at 6 Months

时间窗: 6 months

WMI=\[left ventricular stroke work/decay rate of 11C-acetate\]

次要结局

  • Minnesota Living With Heart Failure Questionnaire,at Baseline(baseline)
  • 6 Minute Walk Test (6MWT) at Baseline(baseline)
  • 6 Minute Walk Test (6MWT) at 6 Months(6 months)
  • Minnesota Living With Heart Failure Questionnaire.at 6 Months(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Marvin W. Kronenberg, M.D.

Professor of Medicine and Radiology

Vanderbilt University

研究点 (1)

Loading locations...

相似试验